Screening for Colorectal Neoplasm in First Degree Relatives of the Affected
Colonoscopic Screening in First-degree Relatives of Hong Kong Chinese Patients With Sporadic Colorectal Cancer: a Cohort Study With Case Control Analysis
1 other identifier
observational
748
1 country
1
Brief Summary
To determine the prevalence of colorectal neoplasms in first degree relatives of those affected with sporadic colorectal cancer using colonoscopy as a screening tool. The prevalence will be compared to that of a defined matched cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2017
CompletedApril 21, 2017
April 1, 2017
12.3 years
September 9, 2005
April 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To find the prevalence of adenomas and advanced neoplasms of the first degree relatives
7 years
Study Arms (2)
FDR of CRC patient
First degree relatives of patients having CRC
FDR of normal colonoscopy
First degree relatives of patients having normal colonoscopy
Interventions
Eligibility Criteria
First degree relatives of patients having CRC or patient having normal colonoscopy
You may qualify if:
- First degree relatives (age \>40 and \<70) of individuals affected with sporadic colorectal cancer (those not associated with inflammatory bowel disease, familial adenomatous polyposis or HNPCC syndrome).
You may not qualify if:
- A family history compatible with that of Hereditary Non-polyposis Colon Cancer (HNPCC) based on the Amsterdam criteria \[Table 5\].
- Known Familial Adenomatous Polyposis (FAP) syndrome
- Patients and relatives with known inflammatory bowel disease
- Severe cardio-pulmonary or other medical co-morbidities that preclude safe colonoscopic examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopy Center, Prince of Wales Hospital
Hong Kong (sar), China
Related Publications (1)
Ng SC, Lau JY, Chan FK, Suen BY, Leung WK, Tse YK, Ng SS, Lee JF, To KF, Wu JC, Sung JJ. Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. Gastroenterology. 2013 Mar;144(3):544-50. doi: 10.1053/j.gastro.2012.11.011. Epub 2012 Nov 13.
PMID: 23159367DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Y Lau, MD
Prince of Wales Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 14, 2005
Study Start
April 1, 2004
Primary Completion
August 1, 2016
Study Completion
April 6, 2017
Last Updated
April 21, 2017
Record last verified: 2017-04